glp 1 coverage 2025 Who Gets the Shot? GLP-1 Access by State GLP-1 Receptor Agonist Market Size,

These medications work by enhancing insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite

However, several limitations warrant consideration when interpreting our findings

Choose lean, protein-dense sources

42% of former GLP-1 users said they would be very likely to resume treatment if cost and side effects were reduced

These agents modulate neurotransmission, reduce neuroinflammation and oxidative stress, enhance mitochondrial and neurotrophic function, and improve insulin sensitivity and hypothalamic-pituitary-adrenal (HPA) axis regulation

It works by mimicking the hormone GLP-1, which the body releases after eating, helping people feel full and slowing stomach emptying